Retinal Therapeutics Innovation Summit

START-END May 1, 2026 from 10:55 AM to 11:10 AM MDT

Presentation Details
Session: Small Molecules to the Rescue
Presentation Title: Topline Results from a 2‑year Phase 3 Study of Oral Tinlarebant in Adolescent Patients with Stargardt Disease
Presenter: Nathan L. Mata, Ph.D., Chief Scientific Officer, Belite Bio
Date & Time: May 1, 2026, 10:55–11:10 a.m. (MDT)
Location: Sheraton Denver Downtown Hotel, 1550 Court Place, Denver, CO

Supporting Materials